Objectives: This study investigated the correlation between antibiotic consumption and antimicrobial resistance in Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009.
Introduction
The incidence of healthcare-associated infection due to Gramnegative bacteria, particularly multidrug-resistant bacteria, has gradually increased over time. 1 -8 Moreover, infections caused by resistant microorganisms are associated with extended length of stay, higher healthcare costs and greater hospital morbidity and mortality. 3, 5 In an international surveillance study in the Asia -Pacific area, Enterobacteriaceae were the most common pathogens causing intra-abdominal infection, comprising 82% of all isolates, and Escherichia coli was the most commonly isolated species (43%). 7 In Taiwan, significant increases in resistance rates were found for cefotaxime-and ciprofloxacinresistant E. coli and cefepime-and ciprofloxacin-resistant Klebsiella pneumoniae from 1991 to 2003. 1 These findings reflect the ongoing evolution of extended-spectrum cephalosporin-resistant and fluoroquinolone-resistant Enterobacteriaceae, which are becoming an increasing global threat due to the difficulty in prescribing appropriate antimicrobial treatment in hospital settings. 1, 8, 9 Glucose non-fermentative Gram-negative bacteria (NFGNB), which are often resistant to a wide range of antimicrobials, 9 accounted for 11.5% of Gram-negative strains collected from clinical specimens and often cause severe infection in immunocompromised and elderly patients worldwide. 10 Among the NFGNB strains, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia were responsible for .80% of clinical NFGNB infections. 10 In a retrospective study, most patients with pan-drug-resistant (PDR) P. aeruginosa infection had received b-lactam antibiotics, fluoroquinolones or carbapenems for prolonged periods and 75.7% of patients had positive cultures for non-PDR P. aeruginosa before the isolation of PDR P. aeruginosa. 11 Among patients with multidrug-resistant Acinetobacter baumannii-related healthcare-associated bacteraemia in a medical centre, 80% had received antimicrobials prior to acquiring the infection. 12 A retrospective study in a university-affiliated referral centre over a 5 year period found a 49% increase in all types of healthcare-associated infections and an 85% increase in healthcare-associated bloodstream infections caused by S. maltophilia. The majority of patients had positive cultures of non-extensively drug-resistant (XDR) S. maltophilia prior to the acquisition of extensively drug-resistant S. maltophilia (XDRSM) (resistant to all the routinely tested antimicrobials, i.e. ceftazidime, cefepime, ticarcillin/clavulanic acid, piperacillin/tazobactam, aztreonam, imipenem, gentamicin, amikacin, levofloxacin, ciprofloxacin and trimethoprim/sulfamethoxazole in hospital), indicating that the use of antibiotics might have resulted in the selection of XDRSM. 13 In addition to intrinsic resistance, such an increase in the prevalence of these resistant pathogens may be related to selective pressure from single or multiple antibiotics or the heavy use of antimicrobials.
Several studies have investigated the relationship between antimicrobial consumption and antibiotic resistance; however, the results of these studies have been inconsistent, possibly due to differences in resistance profiles and antibiotic prescribing practices in different countries. 14 -18 These findings support the necessity of monitoring aggregate antibacterial drug use at local and national levels in order to evaluate the associations between the use of antibiotics and emerging antimicrobial resistances.
This study investigated the correlations between antibiotic consumption and antimicrobial resistance for key healthcareassociated Gram-negative pathogens recovered from 2000 to 2009 at a medical centre in Taiwan.
Materials and methods

Setting
National Taiwan University Hospital is a 2500 bed, academically affiliated medical centre providing both primary and tertiary care in northern Taiwan. The number of annual patient-days at the hospital increased from 624675 in 2000 to 751026 in 2009. Some of the data analysed were included in a previous study. 1 
Antibiotic agents and consumption
Data on annual consumption [defined daily doses (DDDs) per 1000 patient-days] of extended-spectrum cephalosporins (cefotaxime, ceftriaxone, flumoxef, ceftazidime, cefepime and cefpirome), b-lactam/ b-lactamase inhibitor combinations (ticarcillin/clavulanic acid and piperacillin/tazobactam), carbapenems (imipenem, meropenem and ertapenem), aminoglycosides (amikacin and gentamicin) and fluoroquinolones (ciprofloxacin and levofloxacin) from 2000 to 2009 were obtained from the pharmacy department of the hospital.
Bacterial isolates
Healthcare-associated infections were classified by the Infection Control Committee nurse based on diagnostic criteria of the CDC. 19 The organisms causing healthcare-associated infections included E. coli, K. pneumoniae, Enterobacter cloacae, Serratia marcescens, Proteus spp., P. aeruginosa, Acinetobacter spp., S. maltophilia and other NFGNB (Pseudomonas fluorescens, Pseudomonas putida, Acinetobacter junii, Acinetobacter haemolyticus, Acinetobacter lwoffii, Burkholderia cepacia, Chryseobacterium meningosepticum, Chryseobacterium indologenes and Alcaligenes spp.). Isolates were identified by conventional biochemical tests as well as by two commercial identification kits, VITEK identification cards (bioMérieux, Hazelwood, MO, USA) and the Phoenix System (Becton Dickson, Sparks, MD, USA). Isolates were classified as susceptible or resistant (including an intermediate category) according to CLSI guidelines.
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Statistical analysis
Linear regression analysis was used to analyse the trend in the annual consumption of antimicrobial agents and the trend in the nonsusceptible rate of Gram-negative pathogens causing all healthcareassociated infections with time. Pearson's correlation coefficient was used to determine the relationship between annual antibiotic consumption and trends in resistance. A P value ,0.05 was considered statistically significant.
Results
Annual antibiotic consumption
In general, the usage of each antimicrobial agent varied with year (Table 1 and Figure 1 ). Fluoroquinolones were the most commonly used antimicrobials, followed by extended-spectrum cephalosporins. A significant increase in consumption was found for ceftazidime, piperacillin/tazobactam, cefepime and oral levofloxacin from 2000 to 2009 
Antibiotic consumption and resistance
Trend of antimicrobial resistance among Gram-negative bacteria
A total of 23 679 non-duplicate isolates were identified and tested for susceptibility. E. coli was the most common pathogen (n¼5119, 21.6%), followed by K. pneumoniae (n ¼4135, 17.5%) and P. aeruginosa (n¼4095, 17.3%). Table 2 shows the trends of resistance rate among Gram-negative bacteria. A significant increase in the resistance rate with time was found for cefotaxime-and cefepime-resistant E. coli, amikacin-resistant Proteus spp., ceftazidime-resistant P. aeruginosa, meropenem-resistant A. baumannii, cefepime-and piperacillin/tazobactam-resistant S. maltophilia, and cefepimeand ciprofloxacin-resistant other NFGNB. In contrast, the resistance rate significantly decreased with time for gentamicinresistant E. coli, ciprofloxacin-, gentamicin-and amikacin-resistant E. cloacae, cefotaxime-, gentamicin-and amikacin-resistant S. marcescens, and gentamicin-and amikacin-resistant P. aeruginosa. Lai et al. Lai et al.
Correlation between antibiotic consumption and resistance rate
Relationships between the resistance rate of Gram-negative pathogens causing healthcare-associated infections and the annual consumption of the various antibiotics are shown in Tables 3 and 4 . The decreasing use of gentamicin and amikacin in recent years was associated with increasing susceptibility of E. coli, E. cloacae, S. marcescens and P. aeruginosa to gentamicin, and of E. cloacae and P. aeruginosa to amikacin. A positive correlation between the increase in the use of fluoroquinolones and the prevalence of ciprofloxacin-resistant E. coli was noted. Another positive correlation was found between the use of piperacillin/tazobactam and the prevalence of piperacillin/tazobactam-resistant E. coli and S. maltophilia. In contrast, a negative correlation was found between the use of cefotaxime and cefotaxime-resistant E. coli and piperacillin/tazobactam-resistant S. maltophilia.
Correlation between fluoroquinolone consumption and resistance rate
Increased prescription of ciprofloxacin was positively correlated with the rate of gentamicin-resistant A. baumannii and negatively correlated with the rate of ceftazidime-resistant P. aeruginosa. Levofloxacin use was positively correlated with piperacillin/tazobactam-resistant E. coli, A. baumannii and S. maltophilia, amikacin-resistant Proteus spp. and ceftazidimeresistant P. aeruginosa, but negatively correlated with gentamicin-resistant E. cloacae. The consumption levels of ciprofloxacin and levofloxacin were positively correlated with the rate of ciprofloxacin-resistant E. coli, piperacillin/tazobactam-resistant P. aeruginosa and ceftazidime-resistant S. maltophilia.
Discussion
This study evaluated the association between antibiotic consumption and antimicrobial resistance of Gram-negative bacteria causing healthcare-associated infection in a medical centre in Taiwan during a 10 year period. The use of ceftazidime, piperacillin/ tazobactam, cefepime and oral levofloxacin significantly increased with time as well as with the increase in annual patient-days. However, the consumption of ticarcillin/ clavulanic acid, parenteral ciprofloxacin, gentamicin, amikacin, aztreonam, oral trimethoprim/sulfamethoxazole and cefotaxime significantly decreased and the use of other antibiotics, including cefpirome, imipenem, meropenem, oral ciprofloxacin and parenteral levofloxacin, remained stable during the study period. Overall, the trend in consumption of extended-spectrum cephalosporins, b-lactam/b-lactamase inhibitor combinations, carbapenems and fluoroquinolones significantly increased during this recent 10 year period. By contrast, the consumption of aminoglycosides significantly decreased during this period, which is probably attributable to changes in prescription practices due to the notable side effects of these agents. 
JAC
In addition to cefotaxime-resistant E. coli and S. marcescens, the resistance rate of E. coli, E. cloacae, K. pneumoniae and Proteus spp. either did not significantly change with time or declined during the 10 years. For NFGNB, which caused about 40% of Gram-negative bacteria healthcare-associated infection, the trend of ceftazidime-resistant P. aeruginosa, piperacillin/ tazobactam-and meropenem-resistant A. baumannii, cefepimeand piperacillin/tazobactam-resistant S. maltophilia, and cefepime-and ciprofloxacin-resistant other NFGNB significantly increased during this study period. However, the rate of aminoglycoside-resistant P. aeruginosa significantly decreased and became less than 10% during the last 3 years of the study period, which suggests that aminoglycosides remain the drug of choice for combination therapy against P. aeruginosa healthcare-associated infection.
Our review of reports in 2010 on the correlation between antibiotic prescription and the resistance rate in Gram-negative bacteria revealed a non-uniform relationship for each bacterium in different studies (Table 5) . 6, 22, 23 Consistent with a previous study, 1 a positive correlation was found between cefotaxime prescription and cefotaxime-resistant S. marcescens. In contrast, the increased use of cefotaxime exerted a protective effect against the emergence of cefotaxime-resistant E. coli. This study also found various associations between the prescription of piperacillin/tazobactam and subsequent piperacillin/tazobactam resistance, with a positive correlation for E. coli and S. maltophilia isolates, but a negative correlation for S. marcescens isolates. Unlike a previous study, 22 no correlation was found between carbapenem prescription and imipenem-resistant Acinetobacter spp.
In our institute, the impact of using fluoroquinolones, which account for about 40% of all antibiotic consumption, is of great concern. As in previous studies, 22 -24 the associations between the antibiotic resistance rate of bacteria to ciprofloxacin, levofloxacin and ciprofloxacin plus levofloxacin varied. For example, increased ciprofloxacin use exerted a protective effect against the emergence of ceftazidime-resistant P. aeruginosa, but increased levofloxacin use increased this resistance rate. In contrast to the findings of two previous studies, 25, 26 we found that a greater use of fluoroquinolones was associated with an increased proportion of ciprofloxacin resistance among E. coli, as was reported by Hsu et al. 22 In this study, fluoroquinolone resistance of P. aeruginosa was not correlated with prescription of ciprofloxacin, levofloxacin or total fluoroquinolones. These findings are contrary to previous studies which found that increasing levofloxacin 23, 24 or ciprofloxacin 1 use was associated with rising incidence of fluoroquinolone-resistant P. aeruginosa.
It has been proposed that for each antimicrobial agent or class, there is a level of use (consumption threshold) that, once exceeded (i.e. 15-25 DDDs per 1000 patient-days), will eventually lead to emergence of resistance. 27 In this study, it might be difficult to elaborate on this association because the consumption of nearly all antimicrobial agents or classes exceeded the threshold, particularly carbapenems and fluoroquinolones.
There were several limitations of this study. Firstly, the variation in the results of studies which have evaluated the relationship between antibiotic use and subsequent resistance rates might have been partly attributable to inconsistency in the characteristics of patient populations and in the definitions of antimicrobial usage. Secondly, the variation in results may reflect numerous factors, including different prescribing profiles and the resulting selection pressure, different hygiene measures and the emergence and circulation of resistant clones within particular hospitals or in the community. It should also be emphasized that resistance selection pressure occurs at the individual level and calculating antibiotic prescription measurements does not measure individual exposure to antibiotics. Additionally, during the study period, several outbreaks of XDR A. baumannii were reported in the hospital, contributing to overall levels of resistance. 28, 29 Thirdly, co-resistance among different classes and the same classes of antibiotics possibly existed in some antimicrobial -organism combinations, but we did not analyse this association in this study. Finally, the overall tonnage/DDDs of Lai et al.
antibiotics is a notoriously problematic denominator as changes in low-dose usage in specific groups of patients (paediatrics and patients with renal insufficiency) and analysis using number of prescriptions for these patient groups should be more appropriate. The impact should be limited in this study because these specific patient groups constituted a small portion of the study subjects in a primary care centre and the effect would be diluted and equal in each year.
In conclusion, this 10 year study in an institution found that antibiotic use significantly increased during the first 4 years and then remained stable over the next 6 years after the emergence of SARS. However, the correlation between the prescription of individual antibiotic and the rates of resistance of Gramnegative bacteria varied between this study and previous reports in different geographical areas. 6, 22, 23 Therefore, each hospital should monitor the use of antibiotics and further establish the relationship between antimicrobial consumption and the resistance rate of each bacterium.
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